Swiss insulin delivery systems developer CeQur raises over €20m | AltAssets Private Equity News

Subscribe today

Advanced
Search

Swiss insulin delivery systems developer CeQur raises over €20m

6 Jan 2010

CeQur, a company focused on the development and commercialisation of insulin delivery systems to improve the management of type 2 diabetes, has closed its series A funding round on CHF31.7m (€21.4m). Investors include BMC Ventures, Endeavour Vision, Schroder & Co Bank and Venture Incubator.

Sorry, to read the full story you must be a Premium Subscriber

Are you a subscriber?

In order to view premium content you need to be a Premium Subscriber. You can subscribe now to access premium online content.

Become a Premium Subscriber
for only £150 / €180 / $225 p.a.

Login area

If you are already a AltAssets subscriber please log in below.